by PRI | Jun 21, 2022 | Microbiome Research & Technology (public)
Yolanda Sanz Full Professor Microbiome, Intestinal Human Bacteria, Immunity, Body-Brain Interactions, Diet, Obesity, Diabetes, Cardiovascular Disease, Mood, Comorbidities, Microbiome-Based Diagnosis, Prevention and Therapy, Microbiome-Directed Nutrition....
by PRI | Jun 21, 2022 | Microbiome Product Developer
Nikole Kimes CEO & Founder Siolta Therapeutics is a clinical-stage biotech company on a mission to alleviate the suffering of millions impacted by chronic inflammatory diseases through novel microbiome-based medicines....
by PRI | Jun 21, 2022 | Investment | Incubator | Accelerator | Tech Transfer
Isabelle de Cremoux CEO & Managing Partner Seventure Partners finances the development of innovative companies within Life sciences and Digital technologies. We have 20 years of experience which has enabled Seventure to acquire expertise and networks in these two...
by PRI | Jun 21, 2022 | Non classé
Ana Montalban-Arques CEO Recolony Recolony focuses on the development of a live biotherapeutic product for the treatment or prevention of colorectal cancer....
by PRI | Jun 20, 2022 | Microbiome Research & Technology (public)
Graeme Brown CBO At the forefront of research into food, the gut microbiome, and human health, the Quadram is a unique partnership between Quadram Institute Bioscience, the Norfolk and Norwich University Hospitals NHS Foundation Trust and the University of East Anglia...
